Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experience
Authors:
- Fariborz LotfiFLFariborz Lotfi
- Seiied Ali ZargarSZSeiied Ali Zargar
Open Access
- 1 June 2011
- journal article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. 3, 227-231
Abstract
Peer reviewed article authored by (Moslemi MK, Lotfi F, Tahvildar SA). Read article or submit your manuscript for publishing.Keywords
This publication has 30 references indexed in Scilit:
- Should prostate-specific antigen screening be offered to asymptomatic men?Expert Review of Anticancer Therapy, 2010
- Cancer Incidence in Tehran Metropolis: The First Report from the Tehran Population-Based Cancer Registry, 1998-20012009
- Utility of Volume Adjusted Prostate Specific Antigen Density in the Diagnosis of Prostate Cancer in Arab MenInternational Urology and Nephrology, 2005
- Analysis of serum prostate-specific antigen levels in men aged 40 years and older in Yasuj, Iran.2005
- Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5–20 ng/ml in JapanInternational Journal of Clinical Oncology, 2004
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrationsCancer, 1997
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate CancerJournal of Urology, 1992
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987